Chemical Structure (Docetaxel 01)
Docetaxel Injection, Solution
Product Images NDC 0409-0016
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Docetaxel (NDC 0409-0016). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Docetaxel 02)
Figure 2 (Docetaxel 03)
This appears to be a sample data set consisting of survival times in months. It is unclear what the context or purpose of the data set is without additional information.*
Figure 3 (Docetaxel 04)
This appears to be a graph showing cumulative probability and survival times for a medical study. There are percentages given on the left axis with corresponding survival times in months on the right axis. The cumulative probability ranges from 0 to 104. The log-rank p value is given as 0.010, which suggests a statistically significant result.*
Figure 4 (Docetaxel 05)
This appears to be a graph or chart that shows the cumulative probability and survival time in months. It also includes a Log-rank p value of 0.13. The overall meaning and context is not clear without additional information.*
Figure 5 (Docetaxel 06)
Figure 6 (Docetaxel 07)
This is a chart or table structure with the heading "Probability (%)" and "Time (months)". Under "Probability (%)" column, there is a single value of "100". Under "Time (months)" column, there is a single value of "12". It is not clear what the table/chart is representing or measuring.*
Figure 7 (Docetaxel 08)
The text seems to be a chart that shows survival probability in percentage over time in months. It is not completely clear without more context, but it appears that the chart has two data points, one at 1004 months with a survival probability of 21% and another at 1518 months with a survival probability of 24%.*
Figure 8 (Docetaxel 09)
Figure 9 (Docetaxel 10)
This is a graph showing the survival probability over time (in months) of a certain population. The survival probability is represented as a percentage scale ranging from 0 to 100, with intervals of 10. The survival time spans 72 months, or 6 years, and is divided into 5 intervals of 6 months each, starting from 24 months and ending at 48 months.*
Figure 10 (Docetaxel 11)
This table presents the survival probability of patients over time and according to the type of therapy received, either TR or PR. The survival time is measured in months, and the percentage of survival probability is shown at different time intervals. The number of patients analyzed is also presented. There is not enough context to infer the meaning of all the acronyms used.*
Logo (Docetaxel 12)
Logo (Docetaxel 13)
Principal Display Panel (2 mL Vial Label)
This is a 2 mL single-dose vial containing Docetaxel Injection, USP at a concentration of 20mg/2mL (10mg/mL) for intravenous use only. This medication is a cytotoxic agent so caution should be exercised. The medication should be ready to add to infusion solution, and concentration should be checked prior to preparation. The unused portion should be discarded, and the medication should be stored at 20°C to 25°C. Please see the package insert for complete instructions. The product is distributed by Hospira, Inc. and is under the lot number ZHL210082.*
Principal Display Panel (2 mL Vial Carton)
This appears to be information related to a medication called Docetaxel Injection, which comes in a single-dose vial of 20 mg/2 mL for intravenous use only. The package contains instructions for its preparation and administration, and warns that it is a cytotoxic agent that should be kept out of reach of children. The medication should be stored between 20°C to 25°C (68°F to 77°F) and the concentration should be checked beforehand. The package insert provides further information about dosage and usage.*
Principal Display Panel (16 mL Vial Label)
This text represents a medication called Docetaxel, available in a 6mL multiple-dose vial with NDC code 0409-0016-01. Each mL contains 10mg of the medication. It should be stored at 20°C to 25°C and protected from light. It contains citric acid, dehydrated alcohol USP, and polyethylene glycol. Docetaxel is a cytotoxic agent and has a usual dosage that can be found on an insert. It is for intravenous use only and is distributed by Hospira, Inc. with a cautionary warning to check concentration before preparation. The text also includes some additional branding information about Novaplus as a registered trademark of Vizient, Inc.*
Principal Display Panel (16 mL Vial Carton)
This is a product information sheet for Docetaxel, a cytotoxic agent used for intravenous therapy. The formulation is intended to be added to an infusion solution prior to administration. The recommended dosage and handling instructions are available in the package insert. The vial contains 160mg/16mL of Docetaxel with other ingredients like Polysorbate 80 NF, Anhydrous Citric Acid USP, and Polyethylene Glycol 300 NF. The solution is stable for up to 28 days if stored at 2°C to 8°C and protected from light. The sheet includes a warning to keep out of reach of children and to check the concentration before use.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
